Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2013-04-30
2013-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Eye Movement on Toric Lens Orientation and Visual Acuity
NCT00584831
On-Eye Evaluation of Contact Lens Rotation Marks
NCT02055404
Clinical Comparison of Toric Contact Lenses Fit Characteristics
NCT05805345
The Comparative Clinical Performance of Two Daily Disposable Toric Contact Lenses
NCT05020990
Clinical Comparison of Two Daily Disposable Toric Soft Contact Lenses
NCT05483127
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Iteration 2-87-1
Delefilcon A toric contact lenses T1 and T2 worn contralaterally (1 in each eye) for approximately 30 minutes
Delefilcon A toric contact lens T1
Iteration 2-87-1 with embossed mark
Delefilcon A toric contact lens T2
Iteration 2-87-1 without embossed mark
Iteration 2-87-2
Delefilcon A toric contact lenses T3 and T4 worn contralaterally (1 in each eye) for approximately 30 minutes
Delefilcon A toric contact lens T3
Iteration 2-87-2 with embossed mark
Delefilcon A toric contact lens T4
Iteration 2-87-2 without embossed mark
Iteration 2-87-3
Delefilcon A toric contact lenses T5 and T6 worn contralaterally (1 in each eye) for approximately 30 minutes
Delefilcon A toric contact lens T5
Iteration 2-87-3 with embossed mark
Delefilcon A toric contact lens T6
Iteration 2-87-3 without embossed mark
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Delefilcon A toric contact lens T1
Iteration 2-87-1 with embossed mark
Delefilcon A toric contact lens T2
Iteration 2-87-1 without embossed mark
Delefilcon A toric contact lens T3
Iteration 2-87-2 with embossed mark
Delefilcon A toric contact lens T4
Iteration 2-87-2 without embossed mark
Delefilcon A toric contact lens T5
Iteration 2-87-3 with embossed mark
Delefilcon A toric contact lens T6
Iteration 2-87-3 without embossed mark
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Best corrected distance visual acuity greater than or equal to 20/25 in each eye.
Exclusion Criteria
* Anterior segment disease, infection, inflammation, or abnormality that contraindicates contact lens wear.
* History of herpetic keratitis.
* Slit-lamp findings at baseline as specified in the protocol.
* Any use of systemic or ocular medications for which contact lens wear could be contraindicated, including ocular medications that require instillation during contact lens wear.
* Clinically significant dry eye not responding to treatment.
* History of refractive surgery.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joachim Nick, Dipl. Ing.
Role: STUDY_DIRECTOR
Alcon Research
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C-12-061
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.